We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Mylan to Sell Generic Orapred in 2014, Expects First-Filer Exclusivity
Mylan to Sell Generic Orapred in 2014, Expects First-Filer Exclusivity
October 23, 2012
Mylan can begin selling a generic version of Shionogi Pharma’s lung drug Orapred ODT in April 2014 or earlier under certain circumstances per an agreement with the brand drug’s maker.